Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

NCT02641093 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Pembrolizumab
PROCEDURE: Surgery
RADIATION: Radiation Therapy
DRUG: Cisplatin

Sponsor

Trisha Wise-Draper

Collaborators

[object Object]